Corrigendum to "Irbesartan Ameliorates Diabetic Nephropathy by Suppressing the RANKL-RANK-NF-
κ
B Pathway in Type 2 Diabetic db/db Mice"
Mediators Inflamm
.
2016:2016:3151986.
doi: 10.1155/2016/3151986.
Epub 2016 Oct 18.
Authors
Xiao-Wen Chen
1
,
Xiao-Yan Du
1
,
Yu-Xian Wang
2
,
Jian-Cheng Wang
1
,
Wen-Ting Liu
1
,
Wen-Jing Chen
1
,
Hong-Yu Li
1
,
Fen-Fen Peng
1
,
Zhao-Zhong Xu
3
,
Hong-Xin Niu
1
,
Hai-Bo Long
1
Affiliations
1
Department of Nephrology, ZhuJiang Hospital, Southern Medical University, Guangzhou 510280, China.
2
Department of Gerontology, ZhuJiang Hospital, Southern Medical University, Guangzhou 510280, China.
3
Department of Emergency, ZhuJiang Hospital, Southern Medical University, Guangzhou 510280, China.
PMID:
27829706
PMCID:
PMC5088271
DOI:
10.1155/2016/3151986
Abstract
[This corrects the article DOI: 10.1155/2016/1405924.].
Publication types
Published Erratum